Replies to post #143384 on Biotech Values

[rkrw]

Patrick Soon owns 80% of CELGZ (he was the founder and 80% holder of Abraxis). He's not a bad person to have negotiating for you. He's a shark.

I think one problem with the CVR is that if CELG takes a majority holding in it, it can force CVR holders to accept their average price.

[biomaven0]

>CELG CVR

I think the milestone for NSCLC with a PFS label is dead. So really it pretty much all depends on pancreatic.

Peter

[DonShimoda]

True, if CELG acquires a majority of the outstanding CELGZ shares, they can force the remaining shareholders to redeem at the average price paid to acquire the 51%. However, in practicality, given the low float/lack of liquidity, it would likely be difficult for them to acquire the shares "on the cheap."